Natalie Smith, Author at Bioanalytical Lab & Top CRO for Large Molecule Bioanalysis

CLIA, COLA & CAP: What’s the Difference?

Posted by Natalie Smith / August 19, 2020 / BioAgilytix Insight, Regulatory Considerations

BioAgilytix’s CLIA Laboratory Director, Natalie Smith, outlines the differences between CLIA, CAP & COLA regulations & accreditations, and what they mean for laboratory testing quality.

Posted by Natalie Smith / March 18, 2020 / Cell Therapy, Gene Therapy, Regulatory Considerations

It's a common misconception that all aspects of cell & gene therapy research and development are excluded from CLIA oversight. We take a closer look at testing and when CLIA requirements apply.